secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2025-09-30T23:59:59+00:00
Accession:  0001104659-25-094754
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Barinthus (BRNS) merges with Clywedog; Clywedog stockholders to own ~66% of combined company
--------------------------------------------------------------------------------

- Clywedog stockholders will receive ~4.36 Topco shares per Clywedog share; Barinthus shareholders receive 1 Topco share per share.
- Clywedog stockholders to own ~66% of combined entity; Barinthus shareholders ~34%.
- Topco may launch self-tender offer for up to $27M of its common stock prior to Merger close.
- Deal expected to close in H1 2026, subject to shareholder approvals, court sanction, antitrust clearance, and Nasdaq listing.
- Voting agreements cover ~25% of Barinthus shares and all Clywedog shares; lock-ups for six months for certain insiders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465925094754/0001104659-25-094754-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465925094754/tm2527141d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-094754

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer